The New Therapeutic Strategies in Pediatric T-Cell Acute Lymphoblastic Leukemia

Childhood acute lymphoblastic leukemia is a genetically heterogeneous cancer that accounts for 10–15% of T-cell acute lymphoblastic leukemia (T-ALL) cases. The T-ALL event-free survival rate (EFS) is 85%. The evaluation of structural and numerical chromosomal changes is important for a comprehensive...

Descripción completa

Detalles Bibliográficos
Autores principales: Lato, Marta Weronika, Przysucha, Anna, Grosman, Sylwia, Zawitkowska, Joanna, Lejman, Monika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123476/
https://www.ncbi.nlm.nih.gov/pubmed/33925883
http://dx.doi.org/10.3390/ijms22094502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123476/
https://www.ncbi.nlm.nih.gov/pubmed/33925883
http://dx.doi.org/10.3390/ijms22094502

Ejemplares similares